Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-570-6 | CAS number: 70321-86-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
In the key study, 0 out of 20 guinea pigs gave positive results after challenge exposures with the test article. Based on the evaluation criteria of Annex VI of the Commission Directive 67/548/EEC, the evaluation "sensitizing" is warranted when at least 30 % of the test animals exhibit positive skin reactions in an adjuvant test. Therefore, in line with the above argument, the test article is considered not sensitizing after skin contact.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline study without GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- (adopted in 1981)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- Carried out according to the maximization test of Magnusson and Kligman (J. Invest. Dermatol. 52, 268-276, 1969).
- GLP compliance:
- not specified
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- When this test was performed, the LLNA did not yet exist.
- Specific details on test material used for the study:
- - Batch No.: EN 24705
- Purity: techn. qual.
- Appearance: white powder
- Validity: 12/1984
- Stability under the condition of administration: not determined - Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Ciba Geigy AG
- Age at study initiation: ca. 10 wks
- Weight at study initiation: 328 - 468 g
- Housing: individually in macrolon cages (type 3)
- Diet: ad libitum; guinea pig pellets (NAFAG No. 846, Gossau SG), feed was supplemented with fresh carrots
- Water: ad libitum
- Acclimation period: 12 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 55 ± 10
- Photoperiod (hrs dark / hrs light): 14/10 - Route:
- intradermal and epicutaneous
- Vehicle:
- other: Sesame oil (intradermal induction), vaseline (epicutaneous induction and challenge)
- Concentration / amount:
- Intradermal induction: 1 %
Epicutaneous induction: 30 %
Challenge: 30 % - Route:
- epicutaneous, occlusive
- Vehicle:
- other: Sesame oil (intradermal induction), vaseline (epicutaneous induction and challenge)
- Concentration / amount:
- Intradermal induction: 1 %
Epicutaneous induction: 30 %
Challenge: 30 % - No. of animals per dose:
- 20 (10 males + 10 females)
- Details on study design:
- PRELIMINARY TEST: The concentrations of the test compound for the induction and challenge period were determined on separate animals.
MAIN STUDY
A. INDUCTION EXPOSURE
A1. Intradermal Injection
- Site of injection: neck
- Number of injections: 2/ formulation
- Formulations: 1). mixture of adjuvant and saline, 2). test compound in sesame oil (test group) or sesame oil (control group), 3). test compound in the adjuvant saline mixture (test group) or adjuvant saline mixture without test compound (control)
- Volume per injection: 0.1 mL/ formulation
- Evaluation (hr after injection): no data
A2. Epicutaneous induction exposure:
- Time schedule: one week after intradermal inductions
- Site: same as intradermal injections (site was pretreated the day before with 10% sodium lauryl sulphate: open application)
- Concentrations: 30 % (test group), and vehicle (control group)
- Volume applied: no data
- Type of coverage: occlusive
- Duration: 48 hours
- Evaluation (hr after challenge): no data
B. CHALLENGE EXPOSURE (identical treatment for treated and control animals)
- Time schedule: two weeks after topical induction
- Site: flank (one flank: test substance) other flank (vehicle)
- Vehicle: vaseline
- Concentrations: 30 %
- Volume applied: no data
- Type of coverage: occlusive
- Duration: 24 hours
- Evaluation (hr after challenge): 24 and 48 hours after termination of exposure.
- Evaluation method: Draize scoring - Positive control substance(s):
- yes
- Remarks:
- The sensitivity of the strain is controlled every six months with p - phenylenediamine
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 30 % in vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 30 % in vehicle. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: vehicle. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 30 % in vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 30 % in vehicle. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: vehicle. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 30 % in vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 30 % in vehicle. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: vehicle. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 30 % in vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 30 % in vehicle. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: vehicle. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Interpretation of results:
- not sensitising
Reference
Body weights were taken before the start of the treatment and at termination.
Control animals
- At start: Mean (n = 20) = 380.7 +/- 36.66 g
- At termination: Mean (n = 20) = 528.4 +/- 68.74 g
Test group animals
- At start: Mean (n = 20) = 383.3 +/- 31.65 g
- At termination: Mean (n = 20) = 532.1 +/- 54.17 g
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In the key study, the potential of the test article (technical grade) to cause "delayed contact hypersensitivity" after dermal contact was appraised in Pirbright-Hartley Guinea Pigs pursuant to OECD TG 406 (Skin Sensitisation, GPMT). Intradermal inductions were performed with 1% of the test substance in sesame oil. Topical induction (occlusive; 48 hours) and as well as challenge exposures (epicutaneous occlusive; 24 hours) were performed with 30% of the test substance in vaseline. The control and test groups consisted of 20 animals each. Evaluation of the skin reactions were performed 24 and 48 hours after challenge according to the Draize method. After challenge, 0 out of 20 guinea pigs exhibited evidence of "delayed contact hypersensitivity". All animals of the control group did not show evidence of "delayed contact hypersentisation" (0/20). The sensitivity and reliability of the experimental technique was ascertained every 6 months using p - phenylenediamine.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Classification, Labeling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for the purpose of classification under Regulation 1272/2008. Based on the criteria laid down in Regulation (EC) No. 1272/2008, as amended for the fifth time in Directive EC 944/2013, classification as a skin sensitizer is not warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
